VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ISA 2022 | Pre-symptomatic diagnosis of AL amyloidosis with biomarker-based screening in patients with MGUS

Silvia Mangiacavalli, MD, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy, shares the results of a study investigating the possibility of diagnosing pre-symptomatic AL amyloidosis in patients with monoclonal gammopathy of undetermined significance (MGUS) using a biomarker-based screening program. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter